3753 Howard Hughes Parkway
Suite 200
Las Vegas, NV 89169
United States
844 628 2100
https://www.cardifflexington.com
Settore/i: Financial Services
Settore: Asset Management
Impiegati a tempo pieno: 13
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Daniel R. Thompson | Chairman of the Board & Secretary | 610k | N/D | 1949 |
Mr. Alex H. Cunningham | CEO, President & Director | 560k | N/D | 1956 |
Mr. Matthew T. Shafer | Senior VP, CFO & Treasurer | N/D | N/D | 1971 |
Dr. Kevin Fitzgerald M.D. | Managing Director of Nova Ortho & Spine | N/D | N/D | N/D |
Cardiff Lexington Corporation, together with its subsidiaries, operates in health care business in the United States. The company Healthcare, and Real Estate segments. It also provides tax resolution service to individuals and companies that have federal and state tax liabilities; and a range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. In addition, the company engages in the commercial real estate property business. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation is based in Las Vegas, Nevada.
L'ISS Governance QualityScore di Cardiff Lexington Corporation al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.